Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Jen Liu

Showing results (321-330 of 367) with videos related to

Pageof 37
Sort By:
JHEP Reports : Innovation in Hepatology|June 25, 2026
Peripartum ALT Flares Predict Earlier Postpartum HBeAg Clearance in Highly Viremic HBV-Infected Women: A Long-term Follow-up StudyWan-Hsin Wen, Chun-Jen Liu, Ming-Wei Lai, et al.
Gastroenterology|November 28, 2017
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBVChun-Jen Liu, Wan-Long Chuang, I-Shyan Sheen, et al.
Hepatology International|February 3, 2022
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancyManoj Kumar, Zaigham Abbas, Milad Azami, et al.
Journal of Gastroenterology and Hepatology|March 25, 2016
Asian consensus on the relationship between obesity and gastrointestinal and liver diseasesJianyi Calvin Koh, Wai Mun Loo, Khean Lee Goh, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|November 18, 2025
HCV micro-elimination in diabetes care: A multicenter, prospective quality improvement program in TaiwanYu-Cheng Liang, Jun-Sing Wang, Chun-Chuan Lee, et al.
Nature Medicine|November 7, 2025
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trialGrace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin, et al.
The Journal of Infectious Diseases|May 21, 2010
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C virusesMing-Lung Yu, Chuan-Mo Lee, Wan-Long Chuang, et al.
Clinical and Molecular Hepatology|October 4, 2023
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseasesPin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis CChun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.
Scientific Reports|June 18, 2017
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C PatientsMei-Hsuan Lee, Chung-Feng Huang, Hsueh-Chou Lai, et al.
Pageof 37

Showing results (321-330 of 367) with videos related to

Sort By:
Pageof 37
JHEP Reports : Innovation in Hepatology|June 25, 2026
Peripartum ALT Flares Predict Earlier Postpartum HBeAg Clearance in Highly Viremic HBV-Infected Women: A Long-term Follow-up StudyWan-Hsin Wen, Chun-Jen Liu, Ming-Wei Lai, et al.
Gastroenterology|November 28, 2017
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBVChun-Jen Liu, Wan-Long Chuang, I-Shyan Sheen, et al.
Hepatology International|February 3, 2022
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancyManoj Kumar, Zaigham Abbas, Milad Azami, et al.
Journal of Gastroenterology and Hepatology|March 25, 2016
Asian consensus on the relationship between obesity and gastrointestinal and liver diseasesJianyi Calvin Koh, Wai Mun Loo, Khean Lee Goh, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|November 18, 2025
HCV micro-elimination in diabetes care: A multicenter, prospective quality improvement program in TaiwanYu-Cheng Liang, Jun-Sing Wang, Chun-Chuan Lee, et al.
Nature Medicine|November 7, 2025
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trialGrace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin, et al.
The Journal of Infectious Diseases|May 21, 2010
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C virusesMing-Lung Yu, Chuan-Mo Lee, Wan-Long Chuang, et al.
Clinical and Molecular Hepatology|October 4, 2023
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseasesPin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis CChun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.
Scientific Reports|June 18, 2017
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C PatientsMei-Hsuan Lee, Chung-Feng Huang, Hsueh-Chou Lai, et al.
Pageof 37